Cytokinesis in animal cells is accomplished by formation and constriction of a cleavage furrow that divides a cell in two daughter cells. The driving force behind this constriction is an actomyosin contractile ring that forms at the cell equator in late anaphase. The assembly of the contractile ring involves local reorganization of actin filaments around the cell equator into a cortical complex consisting, in addition to actin, of myosin, septins, and other cytoskeletal proteins . In Drosophila, genetic analysis and biochemical studies have led to the identification of a number of genes required for the assembly or function of the contractile ring (Field et al. 1999) . Structural components of the contractile ring include actin, the regulatory light chain of nonmuscle myosin [encoded by spaghetti-squash (sqh), Karess et al. 1991] , septins [Peanut (Pnut) (Neufeld and Rubin 1994) , Septin-1 (Fares et al. 1995) , and Septin-2 (Field et al. 1996) ], and actin-binding proteins cofilin [encoded by twinstar (tsr), Gunsalus et al. 1995] , profilin [encoded by chickadee (chic), Giansanti et al. 1998) , and anillin (Field and Alberts 1995; Giansanti et al. 1999) ]. Mutations in sqh, pnut, tsr, and chic result in a failure of cytokinesis, most likely due to defects in contractile ring organization or function. Yet, little is known about the roles of these proteins in contractile ring assembly, stabilization, constriction, and disassembly or about the molecular machinery regulating actin cytoskeleton reorganization during cytokinesis.
Small guanosine triphosphatases (GTPases) of the Rho family control organization of the cytoskeletal architecture in all eukaryotic cells and have been implicated in many actin-based processes including cell motility, cell adhesion, chemotaxis, axon guidance, and cytokinesis (for review, see Van Aelst and D'Souza-Schorey 1997; Hall 1998) . Rho GTPases act as molecular switches, cycling between inactive (GDP-bound) and active (GTPbound) states. Rho proteins are activated by guanine nucleotide exchange factors (GEFs), which enhance the exchange of bound GDP for GTP, and are inactivated by GTPase-activating proteins (GAPs), which increase the intrinsic GTPase activity of Rho proteins. Activation of Rho GTPases results in a conformational change of the protein revealing structural domains required for the interaction with downstream target proteins. Thus, the intracellular ratio of the GTP/GDP-bound forms of Rho proteins determines the activation of signal transduction pathways regulating the spatial and temporal reorganization of cytoskeletal architecture.
Here, we show that in Drosophila, a putative guanine nucleotide exchange factor (Pbl) and its downstream effector (Rho1 GTPase) are required for the initiation of cytokinesis. We propose a molecular pathway that links a RhoGEF through the activity of small GTPase to reorganization of the actin cytoskeleton at the cell equator leading to the assembly of a contractile ring and initiation of cytokinesis. We provide several lines of evidence suggesting that Pbl is a key regulatory component of this pathway acting upstream of Rho1 to regulate the behavior of cytoskeletal and structural proteins known to be required for cytokinesis.
Results

Mutations in pbl result in the absence of a contractile ring and block of cytokinesis
We and others have demonstrated previously that mutations in pbl lead to a complete block of cytokinesis in mitotic cycle 14 (Hime and Saint 1992; Lehner 1992) . Later rounds of nuclear divisions without cytokinesis result in the formation of polyploid multinucleate cells (Fig. 1A,B ). Other events of the cell cycle (including nuclear envelope breakdown, chromosome condensation, and assembly and function of mitotic spindle) are not affected (Hime and Saint 1992; Lehner 1992) , and during cycle 15 two mitotic figures are formed that independently enter anaphase (Fig. 1C,D) . Affected cells fail to initiate a cleavage furrow (Fig. 1D) , suggesting a defect in contractile ring function. To further characterize the defects in cytokinesis, we examined the localization of actin, Pnut, and anillin, components of the contractile ring, in pbl mutant cells. In wild-type cells, actin is associated with the cell cortex throughout mitosis and accumulates in the equatorial region of the cell, in which the contractile ring is assembled (Fig. 1E) . Anillin, an actin-binding protein required for cytokinesis, is thought to play a role in organizing contractile domains of the actin cytoskeleton (Field and Alberts 1995; Giansanti et al. 1999) . In wild-type cells, anillin accumulates at the cleavage furrow at the onset of anaphase and is restricted to the contractile ring during anaphase and telophase (Fig. 1H) . Pnut, a member of the septin family of proteins (Neufeld and Rubin 1994) , accumulates at the cleavage furrow in late anaphase and is associated with the contractile ring during telophase (Fig. 1J) . During cycle 14 in pbl mutant cells, actin (Fig. 1F) , anillin (Fig. 1I) , and Pnut ( Fig. 1K ) fail to relocalize from the cell cortex to the cleavage furrow. Subsequently, the cleavage furrow is not initiated (arrows in Fig. 1F ,I,K) and cytokinesis fails. Similarly, in later rounds of cell division, actin, anillin, and Pnut fail to accumulate at the equatorial region of the cell, and there are no signs of a cleavage furrow ( Fig.  1G ; data not shown). These results indicate that in pbl mutant cells the contractile ring does not assemble, leading to a failure of cytokinesis.
pbl encodes a novel RhoGEF related to the mouse Ect2 oncoprotein
To clone pbl, we used recently identified P-element alleles of pbl (Salzberg et al. 1997) . Genomic fragments flanking the sites of P-element insertions were isolated and used to screen an embryonic cDNA library. Database searches revealed that pbl encodes a novel guanine Figure 1 . Absence of a contractile ring and failure of cytokinesis in pbl mutants. Wild-type (A) and pbl 5 /pbl 2 (B) embryos stained with anti-␣-spectrin (red) to reveal plasma membrane and anti-lamin (green) to mark nuclei. Ectodermal cells of a wild-type embryo (A) contain only one nuclear lamina (nucleus) per cell, whereas several nuclei can be found in pbl mutant cells (B). Absence of cytokinesis in cell divisions following mitotic cycle 14 results in accumulation of multiple nuclei per cell (arrows). Wild-type (C) and pbl 5 /pbl 2 (D) embryos stained with anti-actin (red) to mark plasma membrane and anti-phosphohistone H3 (green) to mark chromosomes during mitosis. Wildtype cells (C) form a single mitotic apparatus per cell and initiate contraction of the cleavage furrow (arrow) in late anaphase. In polyploid pbl mutant cells (D), there are no signs of cleavage, and during mitotic cycle 15, two mitotic apparatuses are formed (arrows) that independently enter anaphase. Wild-type (E,H,J) and pbl 5 /pbl 2 (F,G,I,K) embryos stained with anti-actin (E-G, green), anti-anillin (H,I, red), and anti-Pnut (J,K, red) as markers of a contractile ring. Embryos in E-G were counterstained with propidium iodide (red) to mark DNA, and embryos in H-K were counterstained with anti-lamin (green) to reveal nuclei. In dividing wild-type cells, actin (E), anillin (H), and Pnut (J) accumulate at the equatorial region in which the contractile ring is assembled during late anaphase. They remain enriched at the equator through telophase (arrows in E,H,J). During cycle 14 in pbl mutant cells, actin (F), anillin (I), and Pnut (K) do not accumulate at the equatorial region and remain associated with plasma membrane. Similarly, during later mitotic cycles (G) there are no signs of contractile ring formation.
nucleotide exchange factor for small G proteins of the Rho family (RhoGEF) related to the mouse Ect2 oncoprotein (Miki et al. 1993 ; Fig. 2A,B) . Common functional domains of Pbl and Ect2 include the Dbl homology (DH) and pleckstrin homology (PH) domains (in Pbl, amino acids 390-574 and 600-718, respectively) that are found in tandem in all RhoGEFs (Whitehead et al. 1997) . Mammalian members of the RhoGEF family are considered to be potential oncogenes as their truncated forms often induce transformed foci when overexpressed in cultured fibroblasts. The DH domain catalyzes GDP/GTP exchange through direct binding to its effector GTPase (Hart et al. 1994; Zheng et al. 1995; Liu et al. 1998) . The PH domain (Shaw 1996) , always carboxy-terminal to the DH domain in RhoGEFs, is thought to be required for membrane or cytoskeletal targeting of the protein and in enhancement of the catalytic activity of the adjacent DH domain (Whitehead et al. 1995; Zheng et al. 1996; Liu et al. 1998; Sterpetti et al. 1999) . At the amino terminus, Pbl and Ect2 share two BRCT (BRCA1 carboxyl terminus) domains (in Pbl, initially identified in the familial breast and ovarian cancer susceptibility gene BRCA1 (Bork et al. 1997; Callebaut and Mornon 1997) . BRCT domains are found in proteins involved in DNA metabolism and cell cycle checkpoint control and are thought to be protein-protein interaction modules. In addition, Pbl contains a putative nuclear localization signal (NLS) (amino acids 306-322) and a PEST sequence (amino acids 371-383) (Fig. 2B) , which often serves as a proteolytic signal to target proteins for rapid degradation.
Several lines of evidence suggest that the pbl cDNA we cloned corresponds to the pbl gene. First, four independently generated P-element alleles that fail to complement other pbl alleles are inserted in the 5Ј-untranslated region (UTR) or open reading frame (ORF) of pbl. Second, each P element is revertible to wild type (Salzberg et al. 1997 ; this study). Third, the molecular lesions associated with three EMS-induced pbl mutations were identified ( Fig. 2A,B) . Mutations in pbl 2 and pbl 3 cause premature termination at Q37 (CAG to TAG) and W185 (TGG to TAG), respectively, whereas a V531D Callebaut and Mornon (1997) and Schultz et al. (1998) , respectively. (C) Mitotic figures in cycle 14 domains of a wild-type embryo stained with anti-Pbl (red) and antiphosphohistone H3 (yellow) to mark chromosomes during mitosis. Pbl protein is not detected during late prophase, metaphase, and anaphase. Pbl has the highest levels of expression in telophase and interphase nuclei.
(GTT to GAT) mutation in pbl 5 affects a conserved valine within the most highly conserved region (CR3) of the DH domain. A mutation in this residue has been shown to dramatically reduce the nucleotide exchange activity of other RhoGEFs (Liu et al. 1998) . We conclude that Pbl is a putative RhoGEF related to the mouse Ect2 protein.
Pbl redistribution during mitosis parallels the onset of cytokinesis
To investigate the subcellular distribution of the protein during the cell cycle, we raised anti-Pbl polyclonal antibodies. Double stainings of wild-type embryos undergoing mitotic cycle 14 with the anti-phospho-histone H3 antibody, which marks chromosomes during mitosis (Hendzel et al. 1997) , revealed that Pbl is expressed dynamically during the cell cycle (Fig. 2C) . We observed no Pbl protein during late prophase, metaphase, and early anaphase. Pbl protein is first detected in late anaphase, when it colocalizes with separating daughter chromosomes. The highest levels of Pbl staining were found in telophase nuclei, and this staining persisted during interphase of the following mitotic cycle. As we never observed Pbl at the onset of mitosis, it appears that it is rapidly degraded during each cycle of cell division, presumably after being released from the nucleus upon disassembly of the nuclear envelope in prophase. Further analyses with antibodies against lamin to mark nuclei and ␣-spectrin to stain plasma membranes demonstrated that in late anaphase, there are low levels of Pbl protein at the plasma membrane and in the cytoplasm (Fig. 3A-C) . Initiation of cytokinesis, as judged by the appearance of the cleavage furrow (arrowheads in Fig. 3B ) and reassembly of nuclear laminae (Fig. 3A) , coincides with the accumulation of Pbl at the cleavage furrow. As the cleavage furrow progresses (arrowheads in Fig. 3E ), Pbl accumulates at the equator between dividing cells (Fig. 3 cf. arrows in D,F,G with A) and in the nuclei of the daughter cells (Fig. 3G) . Pbl translocation to the equatorial region beneath the cleavage furrow (Fig. 3H ) parallels the accumulation of anillin ( Fig. 3I ) and Pnut ( Fig. 3J ) at the equator in which the contractile ring is assembled. In telophase and early interphase cells, the protein is strongly enriched in the nuclei ( Fig. 3K ) and is found at low levels at the cortex (data not shown). Hence, during mitosis subcellular distribution of Pbl undergoes dynamic changes and Pbl is associated with the cleavage furrow during cytokinesis. In addition, the levels of protein cycle during each cell cycle with the highest levels of Pbl in late telophase and interphase.
Embryos homozygous for the pbl 2 null allele as well as cytological deficiencies removing pbl 25] have greatly reduced levels of staining in cycle 15-16 interphase cells (Fig. 3 cf. L with K; data not shown), which is likely to correspond to the remaining maternal contribution. In contrast, pbl 5 embryos that carry the V531D missense mutation affecting a conserved valine ( Fig. 2A,B ) have protein levels comparable with wild type (Fig. 3M ). It is likely that the reduction in the levels of cytoplasmic, but not nuclear Pbl, is responsible for failure of cytokinesis in mitotic cycles 14-16, because we have never observed Pbl at the cortex or at the cleavage furrow during anaphase and telophase in cycle 14 pbl mutant cells (pbl 2 and pbl 5 alleles).
Ectopic expression of amino-terminally truncated Pbl or Ect2 blocks cytokinesis
The dramatic increase in Pbl levels at the onset of cytokinesis and localization of Pbl to the cleavage furrow suggest that Pbl may play a regulatory role in cytokinesis. As a protein, which presumably regulates the activity of Rho GTPases, Pbl may be required for the initiation of cytokinesis or may couple cytokinesis with the mitotic cycle. To investigate this hypothesis, we compared the effects of overexpression of full-length Pbl and of Pbl protein in which the BRCT domains and the NLS sequence were deleted (⌬Pbl325-853 allele) ( Fig. 2A ).
The amino-terminal truncation in ⌬Pbl325-853 resembles a similar mutation in a number of mammalian RhoGEFs (for review, see Whitehead et al. 1997) , including Ect2 (Miki et al. 1993) , that results in the constitutive activation of their transforming potential. However, the amino-terminal sequences that are lost in different RhoGEFs do not share common domains. Hence, their role in controlling the activity of the full-length protein remains elusive. Ectopic expression of full-length Pbl (with pbl EP3415 or the UAS-Pbl 3.2 line) in stage 8-11 embryos with the paired-GAL4 (prd-GAL4) driver did not result in a detectable phenotype (Figs. 4A and 3H) . Although all cells in segments overexpressing Pbl had high levels of exogenous protein in their nuclei and cytoplasm, this did not interfere with cytokinesis, completion of mitosis (arrowhead in Fig. 4A ), or viability. In contrast, expression of ⌬Pbl325-853 with the same driver led to 100% embryonic lethality. Most cells within the embryonic segments expressing ⌬Pbl325-853 became multinucleate (Fig. 4B ). This polyploid phenotype was caused by a failure of cytokinesis, because the cleavage furrow was not initiated (Fig. 4C) , and, likewise, the contractile ring was not assembled ( Fig. 4D ; data not shown). We used the same approach to overexpress the amino-terminally truncated form of Ect2, ⌬Ect2. As for ⌬Pbl325-853, ectopic expression of ⌬Ect2 resulted in the absence of the contractile ring and cleavage furrow, leading to formation of multinucleate cells (Fig. 4E,F) , and lethality. In contrast, flies expressing full-length Ect2 exhibited no phenotype and were viable (data not shown). 2 /+, prd-GAL4/+ embryo expressing full-length Pbl in a prd-like pattern stained with anti-␣-spectrin (red) to mark plasma membrane, anti-lamin (green) to reveal nuclei, and anti-Pbl (blue). Expression of full-length Pbl does not cause a phenotype during cell division, despite high levels of expression of exogenous Pbl in the affected segment (arrows). Note a pair of young postmitotic cells (arrowhead) with high levels of Pbl in the nuclei. High levels of exogenous Pbl and its apparent association with the nuclear envelope cause the nuclear laminae to appear blue. (B,C) Stage 9 UAS⌬Pbl325-853 S4-11 /+, prd-GAL4/+ embryo expressing amino-terminally truncated Pbl stained with anti-␣-spectrin (red) and anti-lamin (green). (D) A similar embryo stained with propidium iodide (red) to mark DNA and anti-actin to mark contractile ring (green). Expression of amino-terminally truncated Pbl leads to a block of cytokinesis. Most cells within the affected segment (arrows in B) become polyploid. During late anaphase, the cleavage furrow fails to initiate (arrowheads in C) and actin does not redistribute to the equatorial region in which the contractile ring is assembled (arrowheads in D). The ⌬Pbl325-853 protein is cytoplasmic and cortical (data not shown). (E) Stage 9 prd-GAL4/UAS-⌬Ect2 S2-1A embryo expressing amino-terminally truncated Ect2 stained with anti-␣-spectrin (red) and anti-lamin (green). (F) A similar embryo stained with anti-anillin (red) to mark the contractile ring and anti-lamin (green). Most cells within the segment expressing ⌬Ect2 (arrows in E) become binucleate. Failure of cytokinesis during later divisions leads to formation of multinucleate cells (arrowhead in E). Similar to ⌬Pbl325-853, there are no signs of a cleavage furrow and anillin does not accumulate at the equatorial region in late anaphase (arrowheads in F). Dotted lines in A,B, and E denote ectodermal segments expressing Pbl or Ect2.
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Thus, it appears that full-length Pbl (as well as Ect2) does not behave in vivo as an active protein, because it does not cause a cytokinetic phenotype when expressed in the embryonic ectoderm. This suggests that activation of the exchange activity of Pbl during cytokinesis may require some initiating event. In contrast, aminoterminally truncated Pbl, when overexpressed in wildtype embryo, has a phenotype similar to lack of pbl. We propose that ⌬Pbl may behave as an activated protein competing with endogenous Pbl for a rate-limiting target protein (such as Rho GTPase), which results in an inappropriate activation of downstream effectors. Furthermore, the amino-terminal BRCT domains of Pbl, lacking in ⌬Pbl and known to be protein-protein interaction modules (Yamane et al. 1997; Chai et al. 1999) , may be required for its regulation by an upstream signal. Such regulation may be essential for the spatial and temporal control of cytokinesis and for the coupling of signaling pathways initiating cytokinesis with other mitotic events.
Identification of Rho1 as a suppressor of pbl
In an effort to identify genes involved in the Pbl signaling pathway, we designed a genetic screen to isolate secondsite mutations interacting with pbl. We used the GMR-GAL4 driver which drives expression in all cells posterior to the morphogenetic furrow (Ellis et al. 1993) to express Pbl in the adult fly eye. Overexpression of Pbl (with the UAS-Pbl 3.2 line) results in a dominant rough eye phenotype characterized by misshaped ommatidia, disrupted bristle distribution (Fig. 5B,G) , misshapen rhabdomeres, and a significant increase in the number of pigment cells (Fig. 5 cf. L with K). In contrast, the external eye morphology of UAS-Pbl 3.2 flies was indistinguishable from wild type. Thus, overexpression of Pbl in the eye perturbs normal retinal development. Furthermore, the developing eye seems to be more sensitive than the embryo to overexpression of Pbl, in which it does not cause a phenotype when expressed in ectodermal cells using the prd-GAL4 driver. To identify dominant second-site modifiers of the rough eye phenotype caused by overexpression of Pbl, the GMR-Pbl flies were crossed to males that carry deficiencies covering most of the II chromosome. The resulting F 1 progeny were examined for dominant enhancement or suppression of the rough eye phenotype. Df(2R)Jp8 deficiency, identified as the only suppressor in the modifier screen, showed an almost complete suppression of the rough eye phenotype (data not shown). One of the genes uncovered by this deficiency is Rho1. To investigate the possibility that a mutation in Rho1 caused the suppression, we analyzed the phenotype of the progeny from a cross between the GMR-Pbl flies and null alleles of Rho1 (Strutt et al. 1997 ). Removal of a single copy of Rho1 dominantly suppressed the rough eye phenotype caused by overexpression of Pbl (Fig.  5C,H) . Transverse sections showed rhabdomeres of more regular shape, number, and arrangement (Fig. 5 cf. M with L). In addition, the number and density of pigment cells is significantly decreased compared with the GMRPbl flies. Hypomorphic alleles of Rho1 cause a similar, but much weaker suppression than Rho1 null mutations (data not shown). In contrast, alleles of Cdc42 or a deficiency removing Rac1 did not suppress or enhance this phenotype (data not shown). These observations suggest that pbl interacts genetically with Rho1 and that the phenotypic suppression is specific for mutations in Rho1, but not for genes encoding other Rho family proteins, Cdc42 and Rac1.
Previously, it was shown that overexpression of Rho1 in the eye results in disruption of both external and internal eye morphology (Hariharan et al. 1995 , and pbl V58 alleles) caused a strong dominant suppression of the GMR-Rho1-induced rough eye phenotype (data not shown). Because pbl encodes a putative RhoGEF, these results suggest that a reduction in exchange factor activity in pbl alleles is responsible for the suppression of the GMR-Rho1-induced eye phenotype. Similarly, we propose that decreased levels of Rho1, a putative effector of Pbl, account for suppression of the GMR-Pbl-induced eye phenotype by Rho1 mutations.
To further characterize the genetic interaction between pbl and Rho1, we generated a new deletion allele of pbl, Pbl⌬DH497-549, which affects the DH domain only ( Fig. 2A) . Site-directed mutagenesis in a number of RhoGEFs revealed that point mutations and deletions within the DH domain completely abolish exchange factor activity (Ron et al. 1991; Hart et al. 1994; Whitehead et al. 1995; Steven et al. 1998) . Hence, to create an inactive form of Pbl that behaves as a dominant-negative protein, we introduced a short deletion (amino acids 497-549) removing the most highly conserved CR3 region (Soisson et al. 1998 ) within the DH domain. Mutations within this region dramatically diminish the DH domain function, suggesting that it is responsible for GTPase binding and nucleotide exchange activity. Expression of Pbl⌬DH497-549 in the eye with the GMR-GAL4 driver results in a rough eye phenotype, with pronounced fusion of some ommatidia and a significant reduction in the number of bristles (Fig. 5D,I ). Transverse sections show a variation in the number of rhabdomeres per ommatidium and, unlike overexpression of the fulllength Pbl, a decrease in the number of pigment cells (Fig. 5 cf. N with L) . This phenotype is significantly enhanced in a dominant fashion by mutations in pbl (data not shown). Similarly, mutations in Rho1 act as dominant enhancers of this phenotype, with a dramatic increase in the number of fused ommatidia and loss of many bristles (Fig. 5E,J) . Transverse sections show a severe disorganization of the internal architecture of the eye, a complete absence of rhabdomeres in some regions of the eye, and a further decrease in the number of pigment cells (Fig. 5O) . Because the Pbl⌬DH497-549 protein is likely to be inactive (see below), we suggest that it may mimic the phenotype of hypomorphic alleles of pbl by sequestering proteins (other than Rho1) that normally bind to or interact with endogenous Pbl. As expected, mutations in Rho1 that interact genetically with pbl enhanced the phenotype of Pbl⌬DH497-549. In summary, pbl shows strong genetic interaction with Rho1, but not with Rac1 or Cdc42, indicating that pbl and Rho1 are in the same genetic pathway in vivo.
Pbl and Rho1 proteins interact in a yeast two-hybrid assay
Exchange factors for Rho proteins are known to activate their downstream targets through direct binding to Rho GTPases (Hart et al. 1994) . Hence, the molecular basis for the observed genetic interaction between pbl and Rho1 may be a physical interaction between Pbl and Rho1 proteins. To test this hypothesis, we carried out a yeast two-hybrid assay. We constructed fusions of Pbl (full-length and amino-terminally truncated) as well as Drosophila Rho proteins, Rho1, Rac1, and Cdc42, with both the GAL4 DNA-binding domain (DBD) and GAL4 activation domain (AD). Plasmids were transformed in various combinations, and the resulting colonies were tested for the ability to activate HIS3 and lacZ reporters. Only colonies that carried plasmids expressing both Pbl (full-length or ⌬Pbl325-853, amino-terminally truncated Pbl) and Rho1 were able to grow on a medium that lacked His, Leu, and Trp (Fig. 6) suggesting that the HIS3 gene was induced. Furthermore, all His-positive colonies expressed ␤-galactosidase (Fig. 6C, sectors a, d , e, and f). In contrast, double transformants coexpressing Pbl and Rac1, Cdc42, or Pbl instead of Rho1, failed to grow on a medium without His, Leu, and Trp (Fig. 6B, sectors b, c,  g, and h ). Therefore, we suggest that Pbl and Rho1 proteins interact in vivo and that this interaction is specific for Rho1, but not for Rac1 or Cdc42. Furthermore, the DH domain, but not the amino terminus of Pbl (containing BRCT domains and NLS), is essential for this interaction, because it was abolished by a small deletion within the DH domain (Pbl⌬DH497-549; Fig. 6A ), but not by the amino-terminal truncation of Pbl (⌬Pbl325-853; Fig. 6B,C, sectors d,f) . These results indicate that Pbl and Rho1 form a protein complex in vivo, and that the basis for the genetic interaction between pbl and 
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Rho1 may be a direct interaction between the two proteins.
Rho1 is required for cytokinesis
To investigate the possibility that mutations in Rho1 cause defects during cell division, we stained Rho1 embryos with antibodies against lamin and ␣-spectrin (Fig.  7A,B) . Embryos homozygous for null alleles of Rho1 (Rho1 72O and Rho1
72R
) showed many binucleate cells in the head region (Fig. 7A) . Occasionally, we also observed a few polyploid cells in thoracic or abdominal segments (Fig. 7B) . Although the latter phenotype was observed with low penetrance, we could never find binucleate ectodermal cells in wild-type embryos. The relatively weak phenotype caused by Rho1 mutations (unlike that of pbl) is most likely due to maternally provided Rho1 protein. Thus, it appears that Rho1 is required for cytokinesis, and that decreased levels of Rho1 may account for the observed phenotype in cytokinesis.
To further demonstrate the role of Rho1 in cytokinesis, we analyzed the effects of expression of a dominantnegative form of Rho1, Rho1
N19 (Strutt et al. 1997 ). It was shown that a dominant-negative form of H-Ras, HRas N17 , cannot interact with downstream target proteins (Farnsworth and Feig 1991; Feig 1999) . In addition, HRas N17 competes with normal H-Ras for binding to ras-GEF, which results in formation of inactive H-Ras N17 -rasGEF complexes and depletion of the pool of the endogenous rasGEF leading to a dominant-negative effect (Schweighoffer et al. 1993; Feig 1999) . Therefore, a dominant-negative Rho1 may produce a phenotype similar to or stronger than loss-of-function alleles of Rho1. Ectopic expression of Rho1 N19 creates a phenotype that is much worse than loss of zygotic Rho1 (Fig. 7 cf. C with A and  B) . Expression of Rho1 N19 in ectodermal stripes leads to a complete block of cytokinesis (Fig. 7D) leading to polyploidy of almost every cell within the affected segment. In contrast, expression of wild-type Rho1 or dominantnegative Rac1 (Rac1 N17 or Rac1 L89 ) did not affect cytokinesis or completion of mitosis (data not shown). Interestingly, coexpression of Rho1 N19 and Pbl (unlike Pbl alone) results in the mislocalization of Pbl to the cell cortex in interphase and late mitotic cells (Fig. 7E,F) further indicating that the two proteins interact during cytokinesis. These results, together with other data, suggest that activation of the Rho1 GTPase by Pbl, its putative exchange factor, is required for the initiation of cytokinesis, because mutations in either protein or overexpression of an inactive protein result in accumulation of multinucleate cells.
Discussion
Pbl is a putative exchange factor required for cytokinesis
Rho GTPases have been implicated in a variety of cellular processes and developmental events. Often the same Rho protein is involved in several interwoven signaling pathways activated within the same cell. The dynamic coordination of these molecular pathways during morphogenesis implies a complex level of regulation of Rho proteins, both spatially and temporally, by guanine nucleotide exchange factors and other molecules (Van Aelst and D'Souza-Schorey 1997). However, our knowledge about the biological functions of RhoGEFs is limited mainly to the studies of mammalian Dbl proteins and their roles in cell growth and oncogenic transformation (Whitehead et al. 1997) . Genetic analyses in Drosophila and Caenorhabditis elegans have led to the identification of exchange factors required for axon guidance and cell migration (UNC-73; Steven et al. 1998) , organization of actin cytoskeleton in synaptic terminals (SIF; Sone et al. 1997) , and for coordination of cell shape changes during gastrulation (DRhoGEF2; Barrett et al. 1997; Hä cker and Perrimon 1998) .
The data presented here indicate that Pbl is the first identified putative RhoGEF specifically required for cytokinesis. First, mutations in all pbl alleles result in the same phenotype-absence of a contractile ring and failure of cytokinesis. Second, during embryogenesis the highest levels of Pbl are found in dividing cells. Third, at the onset of cytokinesis, Pbl is associated with the cleavage furrow. As mitosis progresses, Pbl, localized initially at the cortex and in the cytoplasm, accumulates at the cleavage furrow, where assembly of the contractile ring takes place. We propose that Pbl at the cleavage furrow is required for the initiation of cytokinesis by interacting with and regulating proteins involved in the assembly of the contractile ring. Although the highest levels of Pbl are found in late telophase and young postmitotic nuclei, nuclear Pbl does not seem to play a role in the initiation of cytokinesis. The accumulation of Pbl in telophase nuclei follows the initiation of the cleavage furrow and the beginning of the reassembly of the nuclear envelope and, hence, occurs too late in mitosis to be an instructive signal for cytokinesis. This conclusion is further supported by our observation that amino-terminally truncated Pbl, ⌬Pbl, lacking the NLS and localized to the cell cortex and cytoplasm is able to block cytokinesis. ⌬Pbl may compete with the endogenous Pbl at the cleavage furrow for Rho1 or, possibly, other proteins that bind to Pbl.
What is the function of nuclear Pbl? The translocation of Pbl to the nuclei may be a regulatory mechanism to turn off the downstream signaling cascade by removing a RhoGEF from the cellular compartment in which the cascade was initiated. Alternatively, there may be two pools of Pbl protein-a cytoplasmic/cortical pool required for the initiation of cytokinesis and another pool targeted to nuclei in which Pbl plays some other role unrelated to cytokinesis.
Pbl interacts specifically with Rho1
Recent experimental data suggest that Rho proteins are required, in addition to their well-established roles in cell adhesion, cell motility, chemotaxis, and axon guidance, for the regulation of cytoskeletal events at the cleavage furrow during cytokinesis. Microinjection or expression of a Rho-specific inhibitor or activated forms of RhoA or Cdc42 as well as regulators (rho GDI; Kishi et al. 1993) or downstream effectors (Rho kinase; Yasui et al. 1998) of Rho proteins in sand dollar eggs (Mabuchi et al. 1993) , Xenopus embryos (Drechsel et al. 1996) , and mammalian cells (Dutarte et al. 1996; O'Connell et al. 1999 ) result in the uncoupling of mitosis from cytokinesis, regression of the cleavage furrow, and formation of multinucleate cells. However, genetic evidence supporting the role of Rho family proteins in cytokinesis is limited to the Dictyostelium racE gene that is required for cleavage furrow constriction and completion of cyto- kinesis (Gerald et al. 1998) . Here, we provide in vivo evidence that in Drosophila, both Rho1 and its putative exchange factor are required for the assembly of the contractile ring and, hence, initiation of cytokinesis. Mutations in both Rho1 and pbl result in a similar phenotype-absence of the contractile ring and formation of polyploid cells. We observed similar defects when we ectopically expressed a dominant-negative Rho1, Rho1
N19
. Drosophila Rho1 has been shown to be required for cellularization (Crawford et al. 1998) , gastrulation (Barrett et al. 1997 ; Hä cker and Perrimon 1998), dorsal closure (Harden et al. 1999) , and generation of tissue polarity (Strutt et al. 1997 ), but not for cytokinesis. Our data suggest that the molecular basis of the genetic interaction between pbl and Rho1 is a physical interaction between Pbl and Rho1 proteins, because the two proteins interact in a yeast two-hybrid assay. Both genetic data and two-hybrid assay results indicate that this interaction is specific for Rho1, but not Rac1 or Cdc42. This interaction presumably results in the activation of the Rho1 GTPase by Pbl and induction of the signaling cascade that initiates the assembly of the contractile ring.
Our results illustrate the complexity of the intracellular signaling pathways involving Rho GTPases and their GEFs. In Drosophila, Rho1 has also been identified as a putative effector of DRhoGEF2 (Barrett et al. 1997; Hä cker and Perrimon 1998) , indicating that Rho1 is regulated by at least two RhoGEFs. Given the diversity of developmental roles of Rho1, one would expect that there is a complex hierarchy of molecules regulating its activity, both spatially and temporally, within a cell. Such differential regulation of Rho1 by upstream signals may be achieved through tissue-specific expression of regulatory molecules (such as GEFs and GAPs) restricted to a particular developmental or cell cycle stage. An additional level of regulation within a cell can be achieved through subcellular compartmentalization of the molecular machinery (such as Rho effectors) required for the activation of distinct pathways mediated by Rho GTPases.
Molecular pathway initiating cytokinesis: new insights
Our observations suggest that Pbl is a key regulatory component of the signaling pathway initiating cytokinesis and therefore plays a unique role, different from other cytoskeletal and structural proteins known to be required for cytokinesis . First, unlike other proteins required for cytokinesis, the levels of Pbl protein cycle during each round of cell division. Second, Pbl accumulates at the cleavage furrow at the time when cytokinesis is initiated. Third, Pbl is a putative RhoGEF and our knowledge about mammalian RhoGEFs (Whitehead et al. 1997) clearly implicates them in the regulation of signaling pathways involving Rho GTPases. Fourth, mutations within the catalytic DH domain inactivate Pbl function (pbl 5 allele; Figs. 2B and 3M) and abolish Pbl interaction with Rho1 (Pbl⌬DH497-549 allele; Fig. 6A ). In addition, ectopic expression of Pbl⌬DH497-549 in the embryo or in the eye imaginal disk blocks cytokinesis and results in the formation of polyploid cells (data not shown).
The data presented here together with earlier observations allow us to propose a signaling pathway required for cytokinesis (Fig. 7G) . We suggest that activation of Rho1 GTPase by Pbl is required for initiation of a molecular pathway leading to assembly of a contractile ring. Such activation is likely to be achieved through direct binding of Pbl and Rho1 at the cleavage furrow. This is consistent with data from other species, in which Rho proteins have been shown to localize to the plasma membrane or cytosol in resting cells, but to translocate to the cleavage furrow and midbody during cytokinesis (Adamson et al. 1992; Takaishi et al. 1995; Nishimura et al. 1998) . Pbl has a similar distribution during mitosis, being initially cortical but accumulating at the cleavage furrow at the onset of cytokinesis. Significantly, coexpression of Pbl and a dominant-negative form of Rho1 results in the accumulation of Pbl at the cell cortex in late mitotic cells, suggesting that the two proteins interact during cytokinesis.
Interaction of Rho1 with its effectors is likely to occur at the mouse Diaphanous (Dia) furrow as suggested previously for mouse RhoA and p140mDia, a formin-related protein required for cytokinesis (Watanabe et al. 1997) . Both p140mDia and its Drosophila homolog localize to the cleavage furrow during cytokinesis (Watanabe et al. 1997; Wasserman 1998; Field et al. 1999) . Furthermore, mutations in dia result in the absence of a contractile ring (Giansanti et al. 1998 ) and failure of cytokinesis (Castrillon and Wasserman 1994) . Interestingly, null alleles of dia dominantly suppress the rough eye phenotype of the GMR-Rho1 and GMR-Pbl flies, but dominantly enhance the eye phenotype of the GMR-Pbl⌬DH flies (data not shown), suggesting that the three genes are in the same pathway. In addition, ectopic expression of activated Rho1, Rho1 V14 , but not wild-type Rho1, abolishes cytokinesis (data not shown). Because mouse p140mDia interacts preferentially with activated RhoA, RhoA V14 , but not with wild-type RhoA (Watanabe et al. 1997) , we suggest that Rho1 V14 blocks cytokinesis by titrating out one of its limiting downstream effectors, such as Dia, required for the initiation of cytokinesis. Mouse and Drosophila Dia (Watanabe et al. 1997; Wasserman 1998) , as well as other formin-related proteins implicated in cytokinesis [Bni1p in Saccharomyces cerevisiae (Evangelista et al. 1997 ) and cdc12p in Schizosaccharomyces pombe (Chang et al. 1997) ] bind profilin, an actin-binding protein that regulates F-actin polymerization, in vitro and in vivo. In Drosophila, mutations in profilin [encoded by the chic gene] block the assembly of a contractile ring during meiotic cytokinesis (Giansanti et al. 1998) , and in fission yeast, mutations in both genes-cdc12 (formin) and cdc3 (profilin) show a synthetic lethal genetic interaction (Chang et al. 1997 ).
In conclusion, we propose a linear signaling pathway linking a RhoGEF with the actin cytoskeleton and, hence, the actomyosin contractile ring (Fig. 7G) . All of the components of this pathway have been implicated in cytokinesis and were shown to localize to the cleavage furrow during cytokinesis in Drosophila or other organisms. Furthermore, all of the proteins in the pathway interact in vivo or in vitro with their neighboring partners. We conclude that the activation of Rho1 by Pbl is likely to be an initiating event for the assembly of the contractile ring at the onset of cytokinesis. Identification of upstream components of this pathway will shed light on how cytokinesis is coordinated with the mitotic cycle and on the nature of the signal required for cytokinesis. (Fehon et al. 1997) and Rho1 72O and Rho1 72R alleles (Strutt et al. 1997) were obtained from R. Fehon and M. Mlodzik, respectively. The Df(3L)Ar14-8 deficiency was used as an allele of Rac1. The UAS-Rho1 N19 transgenic lines (Strutt et al. 1997 ) and UAS-Rho1-Sph lines carrying a wild-type Rho1 transgene were kindly provided by M. Mlodzik. The UAS-Rac1 N17 and UASRac1 L89 lines (Luo et al. 1994) were received from L. Luo. The GMR-Rho1 1 Rho1 3 flies (Hariharan et al. 1995) were obtained from J. Settleman. The dia 2 allele (Castrillon and Wassermant 1994) was provided by S. Wasserman. The published breakpoints of the Df(2R)Jp8 deficiency (52F5-9; 53A1) (FlyBase: http://flybase.bio.indiana.edu/) are incorrect, because it fails to complement Rho1 mutations that map at 52E3-6. Canton-S was used as the wild-type strain.
Materials and methods
Fly stocks
Histology, scanning electron microscopy, immunohistochemistry, and confocal microscopy
For histological analyses, adult eyes were incubated in periodate/lysine/paraformaldehyde for 30 min, fixed in 2.5% glutaraldehyde/0.1M sodium phosphate (pH 7.2) overnight, postfixed in 2% osmium tetroxide, washed in water, and dehydrated in acetone. Specimens were mounted in epoxy resin, sectioned at 2 µm, and stained with methylene blue. For scanning electron microscopy, adult eyes were dehydrated through an acetone series, dried in a critical point drier, coated with gold/palladium in a vacuum evaporator, and viewed with a field emission scanning electron microscope (Phillips).
The following primary antibodies were used: anti-actin (C4, 1:20000, ICN Biomedicals), anti-anillin (1:1000; Field and Alberts 1995), anti-lamin A (T47, 1:20; Frasch et al. 1986), antilamin Dm0 (611A3A6, 1:20-1:50; Harel et al. 1989), anti-lamin Dm0 (Rb294, 1:50; Fisher and Smith 1988) , anti-Peanut (4C9H4, partially purified immunoglobulin, 1:20, Developmental Studies Hybridoma Bank, University of Iowa, Iowa City; Neufeld and Rubin 1994), anti-phospho-histone H3 (1:1000, Upstate Biotechnology; Hendzel et al. 1997) , and anti-␣-spectrin (Ab#354, 1:400; Byers et al. 1987) . Secondary antibodies used were Cy3 (1:500), Cy5 (1:250, Jackson ImmunoResearch Laboratories), Alexa488 (1:400, Molecular Probes) IgG (H+L) conjugates, and biotinylated IgG (H+L) (1:200, Vector Laboratories) with streptavidin-Cy5 conjugate (1:1000, Jackson ImmunoResearch Laboratories). DNA was stained with 100 µg/ml propidium iodide (Sigma). Specimens were mounted in Vectashield mounting medium (Vector Laboratories) and analyzed with the MRC-1024 confocal imaging system (Bio-Rad). Images were processed with LaserSharp 3.0 software (Bio-Rad).
Cloning of pbl and sequencing of point mutations
Genomic sequences flanking pbl S008320 and pbl S054203 P-element insertions were isolated by plasmid rescue. Genomic fragments from the 0.8-kb A6 EcoRI (from pbl S008320 ) and 2.8-kb B1 BamHI (from pbl S054203 ) rescues were used to isolate the 1A (3140 bp) and 1C (1642 bp) cDNAs from an embryonic (9-12 hr) cDNA library (Zinn et al. 1988) . Both cDNAs map to 66B, detect two transcripts of 4.0 and 5.5-kb on Northern blots, which are expressed throughout Drosophila development, have the same expression pattern during embryonic development, and correspond to the same gene. Alignment of the sequences of plasmid rescues from pbl 09645 (GenBank accession no. AQ073344), pbl EP3415 (GenBank accession no. AQ254711), pbl
S054203
, and pbl S008320 demonstrates that the P elements are inserted in the 5Ј UTR, 492, 457, and 149 nucleotides upstream of the AUG start codon, and in the ORF of the 1A cDNA, respectively. The 1A pbl cDNA encodes a predicted ORF of 853 amino acids.
To sequence pbl EMS alleles, total RNA isolated from pbl/ TM3 flies was used as a template for first strand cDNA synthesis (Superscript II, GIBCO BRL) with a primer complementary to the 3Ј end of the pbl coding sequence (5Ј-CGCGGATCCT-CAGCTCTAAATGCGGCCCACAAC-3Ј). The entire coding sequence was amplified (Elongase, GIBCO BRL) with the same 3Ј primer and the 5Ј primer (5Ј-CGCGGATCCTGATGGAA-ATGGAGACCATTGAAGAG-3Ј) and cloned subsequently in BamHI sites of pBluescript KS+ (Stratagene). Two independent mutant clones were isolated and sequenced for each pbl allele. Natural polymorphisms made it possible to distinguish mutant clones from those derived from the balancer chromosome. The presence of the CAG to TAG mutation in the pbl 2 allele disrupting the PstI site was confirmed by Southern analysis using the 2-kb EcoRI-BglII fragment of the 1A pbl cDNA as a probe.
Generation of antibodies to Pbl
A 2.4-kb EagI fragment of the 1A pbl cDNA corresponding to amino acids 96-853 was cloned into pET-28b(+) (Novagen) to express amino-terminally tagged His fusion protein. The induced protein was resolved on an SDS-polyacrylamide gel, and protein-containing acrylamide fragments were homogenized and injected into rats and guinea pigs. The following observations suggest that the four immune sera produced (rat R8 and R9 and guinea pig GP14 and GP15) are specific. First, all antibodies give the same pattern of staining in wild-type embryos and on Western recognize a 120-kD protein and several bands of lower molecular mass that are likely to be degradation products. Second, the immune sera recognize an ectopically expressed protein. Third, the antigen detected by immune sera is mislocalized, exhibits decreased levels, or is lacking in pbl mutant embryos. The R8 rat anti-Pbl immune serum was used at 1:800-1: 1000 for indirect immunofluorescence and at 1:5000 for Western.
Generation of pbl and ect2 transgenic lines
The 1A pbl cDNA was cloned in forward or reverse orientation into pUAST to generate UAS-Pbl and UAS-antisensePbl transgenic lines, respectively. A fragment of the pbl cDNA correExchange factor for Rho1 required for cytokinesis GENES & DEVELOPMENTsponding to amino acids 325-853 was amplified (Elongase, GIBCO BRL) and cloned into pUAST to generate UAS⌬Pbl325-853 transgenic lines. To generate UAS-Pbl⌬DH497-549 transgenic lines, 1.94-kb EcoRI-ScaI and 1.04-kb SpeI(filledin)-EcoRI fragments of the 1A pbl cDNA were coligated with pUAST digested (Miki et al. 1993) with EcoRI. Full-length ect2 cDNA (from pCEV27-ect2-F; and amino-terminally truncated ect2 cDNA (from p3N-11/ATG; Miki et al. 1993) were cloned into pUAST to generate UAS-Ect2 and UAS-⌬Ect2 transgenic lines, respectively. To assess the relative strength of different lines with independent insertions of a transgene, they were crossed to GMR-GAL4, dpp-GAL4, and 32B-GAL4 drivers, and adult flies were analyzed for abnormalities in eye and/or wing development. The phenotypes ranged from lack of visible defects to 100% pupal lethality. For overexpression studies, the following transgenic lines were selected: UAS-Pbl , UAS-Ect2 S3-19 , UAS-⌬Ect2 S2-1A, and UAS-⌬Ect2 S2-3 . The RG1 prd-GAL4 driver was used for ectopic expression of proteins in stage 8-11 embryos.
GMR-Pbl (GMR-GAL4, UAS-Pbl
3.2
) and GMR-Pbl⌬DH (GMR-GAL4, UAS-Pbl⌬DH497-549 5B, 6A ) are recombinant II chromosomes carrying the GMR-GAL4 driver and one UAS-Pbl transgene (from line 3.2) and two copies of the UAS-Pbl⌬DH497-549 transgene (from lines 5B and 6A), respectively. Expression of pbl transgenes in eye imaginal disks and in embryos was confirmed immunohistochemically.
Yeast two-hybrid interaction assay
ORFs of Rho1, Rac1, Cdc42, ⌬Pbl325-853, Pbl⌬DH497-549, and 1A pbl cDNA were cloned into pAS2 and pACT2 to create GAL4 DBD and AD fusions, respectively. Plasmids were cotransformed in various combinations in yeast strain PJ69-4A (James et al. 1996) , and transformants were selected on SC−His−Leu−Trp medium. His + colonies were tested for ␤-galactosidase activity on SC−Leu−Trp medium.
